February 8, 2023 from Cannabis Health
The animal study was carried out by scientists from the Center for Research and Advanced Studies of Neurological Diseases at the Siglo XXI National Medical Center on a proprietary CBD product produced by US company HempMeds.
The company said in a press release that researchers demonstrated the oral administration of CBD has the ability to reduce excessive release of glutamate in the cerebral cortex that can lead to TBI.
